Why equine prepurchase exams are getting more complex
Bottom line
Equine Management is spotlighting how equine prepurchase exams have shifted from a relatively straightforward screening into a higher-stakes risk assessment shaped by rising horse values, more extensive imaging, insurance considerations, and greater litigation pressure. In its May 22 report, Alexandra Beckstett summarized discussion from the March 5, 2026 National Equine Forum, where veterinarians and industry participants said today’s PPE is less about “pass or fail” and more about whether a specific horse is suitable for a specific buyer’s intended use. The panel also emphasized that findings can change with management, workload, rider, and environment, making clear communication and careful documentation central to the process. (equimanagement.com)
Why it matters: For equine veterinarians, the story is a reminder that PPEs are as much about expectation-setting as diagnostics. Merck notes that PPEs in the U.S. aren’t standardized and can range from a basic physical and soundness exam to a far more comprehensive workup with imaging, laboratory testing, and video documentation. Cornell and AAEP materials similarly stress that the veterinarian’s role is to assess risk at a single point in time, not guarantee future performance, which raises the stakes for informed consent, conflict-of-interest disclosure, private communication with the buyer or their representative, and a written record that explains both findings and limitations. (merckvetmanual.com)
What to watch: Expect continued debate over standardization, radiograph interpretation, seller disclosure tools, and whether clearer PPE frameworks can reduce disputes while keeping equine practitioners willing to offer the service. (beva.org.uk)
Key facts
- Topic
- Equine prepurchase exams
- Core shift
- From pass-fail screening to risk assessment
- Key date
- May 22, 2026 report
- Forum date
- March 5, 2026 National Equine Forum
- Main factors changing PPEs
- Higher horse values, insurance pressures, and litigation risk
- Exam scope
- Can range from a basic physical and soundness exam to imaging, laboratory testing, and video documentation
- Standardization
- U.S. PPEs are not standardized
- Clinical limitation
- Assesses risk at a single point in time, not future performance
- Documentation focus
- Clear communication and careful documentation are central
Equine prepurchase exams are getting more complicated, and more consequential. A new EquiManagement report published May 22, 2026, argues that the modern PPE now sits at the intersection of clinical judgment, client communication, insurance scrutiny, and legal risk, reflecting concerns raised during a March 5 panel at the 2026 National Equine Forum in London. The central message: a PPE is no longer best understood as a simple gatekeeping exam, but as a risk assessment tied to a particular horse, a particular buyer, and a particular intended use. (equimanagement.com)
That framing isn’t entirely new, but it’s becoming more urgent. Cornell’s equine specialists have described the PPE as a single-day assessment of health and soundness that should not be treated as a pass-fail test or a guarantee of future health. Merck’s current veterinary guidance makes the same point and adds that U.S. PPEs remain non-standardized, with wide variation in scope depending on the horse, discipline, buyer expectations, and practitioner approach. In other words, the exam has always involved judgment, but the consequences of that judgment appear to be growing. (vet.cornell.edu)
According to EquiManagement’s coverage of the National Equine Forum session, panelists said higher horse values, more demanding clients, insurance pressures, and a stronger litigation culture have all changed the PPE landscape. The article cites BEVA chief executive David Mountford and veterinary projects officer Lucy Grieve, along with practitioners including Sam Cutts and Mark Georgetti, who argued that the purpose of the exam is risk reduction, not certainty. EquiManagement also reported that changes in environment, training surface, rider, workload, and day-to-day management can expose issues that were not evident at the time of the vetting, underscoring the limits of any one-time exam. (equimanagement.com)
The technical side has expanded, too. Merck says modern PPEs can include advanced imaging, laboratory testing, and video documentation, while Cornell notes that a full radiographic set for many sport horses may involve 40 to 42 views. That added detail can help buyers and their advisors make better-informed decisions, but it also introduces more gray areas, especially when imaging abnormalities are common and their clinical significance is uncertain. Merck explicitly notes that a comprehensive PPE will identify some abnormal findings in almost every horse, leaving the veterinarian to interpret what matters for the buyer’s intended use. (merckvetmanual.com)
Industry and expert commentary points in the same direction: communication may now be as important as the exam itself. Merck recommends disclosing any current or past relationship with the seller, ideally in writing, and says the buyer should identify a main point of contact who can approve added diagnostics during the exam. Cornell similarly advises a detailed pre-exam conversation about goals, costs, and communication pathways, especially when trainers, agents, or non-local veterinarians are involved. AAEP’s buyer-facing guidance also stresses that the veterinarian’s role is to provide objective information, discuss existing medical problems, and help the buyer make an informed decision, not to “pass” or “fail” the horse. (merckvetmanual.com)
Why it matters: For veterinary professionals, this is really a practice-management and risk-management story as much as a clinical one. If PPEs are becoming more legally sensitive and emotionally charged, then the protective tools are familiar but increasingly essential: define the intended use before the exam, clarify who the client is, disclose conflicts, document recommendations and declined diagnostics, explain uncertainty in plain language, and avoid presenting findings as guarantees. The lack of U.S. standardization may preserve flexibility, but it also means clinics need their own consistent workflows, report templates, and communication standards to reduce misunderstandings and support defensible clinical reasoning. (merckvetmanual.com)
There’s also a workforce angle. Coverage of the National Equine Forum discussion suggests the current pressure around vettings may be discouraging some veterinarians, particularly younger practitioners, from taking on PPE work. That’s an important signal for equine practice leaders: if the service becomes viewed as high-risk, low-reward, access could tighten for buyers and pet parents participating in the horse market, while referral concentration could increase among a smaller pool of experienced clinicians. That inference is supported by forum-related reporting, though the long-term effect on service availability remains to be seen. (yourhorse.co.uk)
What to watch: The next phase will likely center on whether the profession can bring more consistency to reporting, radiograph interpretation, and seller disclosure without losing the case-by-case judgment that makes PPEs useful; BEVA’s guidance resources and recent seller disclosure tools suggest that at least some parts of the industry are already moving in that direction. (beva.org.uk)